Showing results (81-90 of 119) with videos related to
Sort By:
Pageof 12
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 23, 2016
Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT ratesEmre Tekgündüz, İrfan Şencan, Arif Kapuağası, et al.Journal of Hematology & Oncology|May 29, 2021
Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMTJaime Sanz, Jacques-Emmanuel Galimard, Myriam Labopin, et al.Hematology/Oncology and Stem Cell Therapy|January 12, 2023
Current Practice of Oral Care for Hematopoietic Stem Cell Transplant Patients: A Survey of the Eastern Mediterranean Blood and Marrow Transplantation GroupHani Mawardi, Nathaniel Treister, Osama Felemban, et al.Bone Marrow Transplantation|July 14, 2022
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Myriam Labopin, Dietrich Wilhelm Beelen, et al.Leukemia|May 13, 2020
Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemiaArnon Nagler, Bhagirathbhai Dholaria, Myriam Labopin, et al.Bone Marrow Transplantation|October 10, 2022
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working partyNicole Santoro, Jarl E Mooyaart, Raynier Devillier, et al.Bone Marrow Transplantation|February 27, 2022
Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMTEdouard Forcade, Sylvie Chevret, Jürgen Finke, et al.The Lancet. Haematology|January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2019
Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow TransplantationMartin Carré, Raphaël Porcher, Jürgen Finke, et al.Bone Marrow Transplantation|January 15, 2022
Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMTRyszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.Pageof 12